Rhi Magnesita India Limited announces a leadership change

Mr. Pankaj Malhan was appointed as a Director and Managing Director & CEO of RHI Magnesita India for a five-year term, effective 1 July 2026 through 30 June 2031. The appointment was approved by shareholders at the company’s 16th AGM on 29 September 2026. ^[1]

The regulatory disclosure cited does not specify:

• the fixed salary or other fixed remuneration;
• the variable-pay component or its quantum;
• performance-linked incentives, targets, metrics, or payout conditions; or
• any stock options, bonuses, commission, or other incentive arrangements.

Accordingly, the filing establishes the tenure and role, but does not provide a disclosed fixed-versus-variable compensation breakdown or performance-incentive terms. ^[1]

The appointment disclosure defines Mr. Malhan’s mandate as overall executive leadership of RHI Magnesita India, rather than as a separately quantified project mandate. Shareholders approved his appointment as Director and Managing Director & CEO for five years, from 1 July 2026 to 30 June 2031. ^[1]

It does not expressly assign him a specific integration KPI for the Dalmia OCL business, nor does it attach a stated refractory-capacity target, commissioning deadline, or capacity-linked remuneration metric to the appointment. Accordingly:

• Dalmia OCL integration: the disclosure does not define milestones, timelines, or reporting obligations for the ongoing integration.
• Capacity expansion: the disclosure does not set a new target under Mr. Malhan’s mandate. Separately, a company-history update records the Bhiwadi isostatic-capacity expansion from 9,300 tonnes per year to 11,700 tonnes per year as successfully commissioned, but this is an operating update rather than a term of his appointment. ^[2]

The practical reading is that integration execution and capacity expansion fall within his broad CEO responsibilities, but the appointment filing itself does not convert either into a formally disclosed, measurable mandate.

The appointment filing does not specify a formal transition or handover period. It records Pankaj Malhan’s appointment as Director and MD & CEO for five years, effective 1 July 2026 to 30 June 2031, with shareholder approval obtained at the AGM on 29 September 2026.^[1] There is no stated period of joint executive responsibility, shadowing, or overlap with the outgoing MD.

There is, however, governance-level continuity: Parmod Sagar, the former Chairman, MD & CEO, continued as non-executive Chairman from 1 July 2026.^[3] That means the outgoing executive remains involved at Board level, but it should not be described as an overlap in the MD/CEO role or as a documented operational handover.

Alignment with the global group

The structure is broadly aligned in principle with the global RHI Magnesita governance model:

• Malhan holds the executive operating mandate as Indian MD & CEO and is also a Director of the Indian company.^[1]
• Sagar’s continuation as non-executive Chairman separates Board oversight from day-to-day management, which is consistent with the group’s emphasis on Board-led governance.
• At the global level, RHI Magnesita N.V. has a one-tier Board that is collectively responsible for the group’s affairs, supported by Audit and Compliance, Sustainability, Remuneration, and Nomination & Governance committees.^[4]

The important limitation is that the Indian appointment filing does not state that Malhan reports directly to the global Group CEO, the parent Board, or any specific global committee. Accordingly, the evidence supports a locally accountable MD/CEO operating under the Indian Board, with group-level governance alignment at the oversight level—not a documented direct reporting line into the parent’s executive structure.